DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
OSU-6162 is an investigational drug.
There have been 6 clinical trials for OSU-6162. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2007.
The most common disease conditions in clinical trials are Neuroma, Oligodendroglioma, and Thrombosis. The leading clinical trial sponsors are Ohio State University, University of Minnesota - Clinical and Translational Science Institute, and Massachusetts Eye and Ear Infirmary.
Recent Clinical Trials for OSU-6162
|Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans||Washington University School of Medicine||Phase 2|
|Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma||Johns Hopkins University||Phase 0|
|Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma||Mayo Clinic||Phase 0|